Gender interaction of uric acid in the development of hypertension

References

• Sundstrom J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45(1):28–33.
   PubMed Web of Science ®Google Scholar
• Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR, Herrington DM. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006;48(6):1037–42.
   PubMed Web of Science ®Google Scholar
• Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonja AA. Uric acid and the development of hypertension: the normative aging study. Hypertension. 2006;48(6):1031–36.
   PubMed Web of Science ®Google Scholar
• Shankar A, Klein R, Klein BEK, Nieto FJ. The association between serum uric acid level and long term incidence of hypertension: population-based cohort study. J Hum Hypertens. 2006;20(12):937–45.
   PubMed Web of Science ®Google Scholar
• Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol. 2007;18(1):287–92.
   PubMed Web of Science ®Google Scholar
• Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension. 2007;49(2):298–303.
   PubMed Web of Science ®Google Scholar
• Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens. 2001;19(7):1209–15.
   PubMed Web of Science ®Google Scholar
• Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, Kamide K, Rakugi H. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res. 2012;35(11):1087–92.
   PubMed Web of Science ®Google Scholar
• Krishnan E, Kwoh CK, Schumacher HR, Kuller L. .Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension. 2007;49(2):298–303.
   PubMed Web of Science ®Google Scholar
• Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR. Herrington DM. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006;48(6):1037–42.
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Maruyama Y, Nishio S, Takahashi Y, Kidoguchi S, Kobayashi C, Takahashi D, Sugano N, Hosoya T, Yokoo T. Serum uric acid and the incidence of CKD and hypertension. Clin Exp Nephrol. 2015;19(6):1127–34.
   PubMed Web of Science ®Google Scholar
• Nishio S, Kuriyama S, Hosoya T, Yokoo T. Hyperuricemia as a risk factor for the development of hypertension and chronic kidney disease –A 8-year follow-up study-. Gout Nucleic Acid Metab. 2016;40(1):33–46. [in Japanese].
   Google Scholar
• Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642–50.
   PubMed Web of Science ®Google Scholar
• Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63(1):102–10.
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. on behalf of the collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
   PubMed Web of Science ®Google Scholar
• Wang J, Qin T, Chen J, Li Y, Wang L, Huang H, Li J. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One. 2014 Dec 1;9(12):e114259. doi:10.1371/journal.pone.0114259. ( eCollection 2014).
   PubMed Web of Science ®Google Scholar
• Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62(2):170–80. [ PubMed: 20191515].
   PubMed Web of Science ®Google Scholar
• De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis. 2010 Jun;69(6):1162–64. doi:10.1136/ard.2009.122770. [ Epub 2010 Feb 2].
   PubMed Web of Science ®Google Scholar
• Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–21.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Feig DI, Kang DH, Herrera-Acosta J. Resurrection of uric acid as a causal risk factor for essential hypertension. Hypertension. 2005;45:18–20.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kang DH, Feig D, Sanchez-Lozada LG, Srinivas TR, Sautin Y, Ejaz AA, Segal M, Johnson RJ. Unearthing uricacid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 2006;69(10):1722–25.
   PubMed Web of Science ®Google Scholar
• Feig DI, Mazzali M, Kang DH, Nakagawa T, Price K, Kannelis J, Johnson RJ. Serum uric acid: a risk factor and a target for treatment? J Am SocNephrol. 2006;17(suppl 2):S69–S73.
   Google Scholar
• Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, Sánchez-Lozada LG, Gersch M, Rodriguez-Iturbe B, Kang DH, et al. Essentia lhypertension, progressive renal disease, and uric acid: apathogenetic link? J Am Soc Nephrol. 2005;16:1909–19.
   PubMed Web of Science ®Google Scholar
• Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matsuoka Y, Okada M, Yamaguchi M, Yosida H, Morisawa MT. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 2000;10:403–09.
   PubMedGoogle Scholar
• Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodríguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913–23.
   PubMed Web of Science ®Google Scholar
• Goicoechea M, De Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010 Aug;5(8):1388–93. doi:10.2215/CJN.01580210. [ Epub 2010 Jun 10].
   PubMed Web of Science ®Google Scholar
• Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M, Johnson RJ. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002;40(3):355–60. [ PubMed: 12215479].
   PubMed Web of Science ®Google Scholar